Live Breaking News & Updates on Society Of Urologic Oncology Annual Meeting

Stay updated with breaking news from Society of urologic oncology annual meeting. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

ChatGPT Exhibits "Poor Performance" When Classifying Patients With Prostate Cancer

ChatGPT produces mixed results when evaluating patients with prostate cancer, new research suggests. ChatGPT produces mixed results when evaluating patients with prostate cancer, new research suggests. ....

National Comprehensive Cancer Network , Society Of Urologic Oncology Annual Meeting , Urologic Oncology Annual Meeting ,

Surgery After ICI Therapy Appears Safe for Locally Advanced RCC

Surgery after neoadjuvant treatment with immune checkpoint inhibitors is safe for patients with locally advanced RCC, a small study suggests. Surgery after neoadjuvant treatment with ICIs is safe for patients with locally advanced RCC, a small study suggests. ....

Society Of Urologic Oncology Annual Meeting , Urologic Oncology Annual Meeting ,

UGN-102 Yields CRs in 4 out of 5 Patients With Intermediate-Risk NMIBC

UGN-102 produced a high complete response rate in patients with low-grade, intermediate-risk NMIBC in the phase 3 ENVISION trial. UGN-102 produced a high complete response rate in patients with low-grade, intermediate-risk NMIBC in the phase 3 ENVISION trial. ....

New Jersey , United States , Sandip Prasad , Morristown Medical Center , Urogen Pharma Ltd , Society Of Urologic Oncology Annual Meeting , Urologic Oncology Annual Meeting , Urogen Pharma ,

ChatGPT Exhibits "Poor Performance" When Classifying Patients With Prostate Cancer

ChatGPT produces mixed results when evaluating patients with prostate cancer, new research suggests. ChatGPT produces mixed results when evaluating patients with prostate cancer, new research suggests. ....

Society Of Urologic Oncology Annual Meeting , National Comprehensive Cancer Network , Urologic Oncology Annual Meeting ,

Why Patients With Bladder Cancer Aren't Receiving Recommended Immunotherapy

Age, sex, insurance status, and other factors were associated with receipt of immunotherapy in a study of patients with metastatic bladder cancer. Age, sex, insurance status, and other factors were associated with receipt of immunotherapy in patients with metastatic bladder cancer. ....

Society Of Urologic Oncology Annual Meeting , National Cancer Database , Urologic Oncology Annual Meeting ,